Are TG2 inhibitors able to decrease gliadin-induced toxicity related to celiac disease? A proof-of-concept study
- Lindfors, K. (Speaker)
- Tiina Rauhavirta (Speaker)
- Rami Kivistö (Speaker)
- Pekka Männistö (Speaker)
- Arturo Garcia-Horsman (Speaker)
- Martin Griffin (Speaker)
- Mäki, M. (Speaker)
- Kaukinen, K. (Speaker)
Activity: Talk or presentation › Conference presentation